Tag Archive

Tag Archives for " immunotherapy "

What Makes This Gerson Cancer Treatment Different at CHIPSA?

gerson chipsa

The history of CHIPSA Hospital is in a way, the history of Gerson Therapy itself. We are known as the Gerson Therapy hospital because our hospital was founded by Charlotte Gerson, the daughter of Max Gerson, the man who created the Gerson Immuno-Nutrition Protocol. The hospital that is now CHIPSA began using the Gerson Protocols […]

Continue reading

Historic Event Unites 22 Late-Stage Cancer Survivors with Top Scientists From Around the World!

  Last November, CHIPSA Hospital hosted a unique, first-of-its-kind event celebrating the lives of 22 late stage cancer survivors who, according to doctors, shouldn’t even be alive. Surrounded by world-renowned doctors, scientists, and researchers, these patients shared their inspiring stories of how they healed their terminal disease when conventional treatment had failed them.     […]

Continue reading

Keytruda Now FDA-Approved for Patients with Melanoma

Melanoma

The KEYNOTE-054 Phase 3 clinical trial (NCT02362594) showed that the immune checkpoint inhibitor drug Keytruda decreased the risk of melanoma recurrence or death by 43% in comparison to a placebo drug. The drug has thus been approved by the U.S. Food and Drug Administration (FDA) to treat patients with stage-3 melanoma (cancer has spread to […]

Continue reading

Research Team Discovers New Immune “Checkpoint” Protein

immunotherapy

A recent report in the journal Cell showed that a team led by Vanderbilt researchers has found a new “checkpoint” protein on immune system cells in active, malignant tumors. In mouse models, blocking this protein, along with using other treatments, has been an effective approach to treating cancerous cells. Checkpoint proteins are an important component of […]

Continue reading

Study Shows Better Immunotherapy Outcomes in Tumors with More Mutations

Immunotherapy

A recent study published in Nature Genetics called “Tumor mutational load predicts survival after immunotherapy across multiple cancer types” revealed that tumors with more mutations had better results with immunotherapy treatment. The study looked at data from 1,662 metastatic cancer patients who received checkpoint inhibitor therapy, and data from over 5,000 patients who were not treated […]

Continue reading

Researchers Use AI to Improve Immunotherapy Outcomes

immunotherapy

A research team from the University of Maryland is utilizing artificial intelligence (AI) to determine the most effective ways to treat cancer patients with immunotherapy. Immunotherapy takes advantage of the body’s own immune system to fight off cancer, and in the past decade, it has been very successful in treating patients with localized and advanced […]

Continue reading